Dataset on structure, stability and myocardial effects of a new hybrid aspirin containing nitrogen monoxide-releasing molsidomine moiety by Szőke, Kitti et al.
Data in brief 25 (2019) 104146Contents lists available at ScienceDirect
Data in brief
journal homepage: www.elsevier .com/locate/dibData ArticleDataset on structure, stability and myocardial
effects of a new hybrid aspirin containing
nitrogen monoxide-releasing molsidomine
moiety
Kitti Sz}oke a, Attila Czompa a, Istvan Lekli a,
Peter Szabados-Fürjesi a, b, Mihaly Herczeg c,
Magdolna Csavas c, Aniko Borbas c, Pal Herczegh c, **,
Arpad Tosaki a, *
a Department of Pharmacology, Faculty of Pharmacy, University of Debrecen, Debrecen, Hungary
b Department of Bioanalytical Chemistry, Faculty of Pharmacy, University of Debrecen, Debrecen, Hungary
c Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Debrecen, Debrecen, Hungarya r t i c l e i n f o
Article history:
Received 4 March 2019
Received in revised form 24 May 2019
Accepted 4 June 2019




MolsidomineDOI of original article: https://doi.org/10.1016/
* Correspondig author.
** Corresponding author.
E-mail addresses: herczeghp@gmail.com (P. He
https://doi.org/10.1016/j.dib.2019.104146
2352-3409/© 2019 The Authors. Published by Els
creativecommons.org/licenses/by/4.0/).a b s t r a c t
Herein 1H and 13C NMR spectra of ERJ-500, a new hybrid aspirin
derivative, covalently conjugated to nitrogen monoxide donor
linsidomine are presented as well as NMR spectra of its synthetic
intermediate compounds. HPLC-MS measurements data are also
included, demonstrating the stability of the linsidomine-aspirin
hybrid in oxidation reactions. This data article also concerns
miscellaneous myocardial parameters of isolated rat hearts as a
complementation of the tables shown in the paper entitled “A
new, vasoactive hybrid aspirin containing nitrogen monoxide-
releasing molsidomine moiety” Szoke et al., 2019. Column tables
represent data of aorta ﬂow, aortic pressure, derivated aortic
pressure and cardiac output.
© 2019 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license (http://creativecommons.
org/licenses/by/4.0/).j.ejps.2019.02.020.
rczegh), tosaki.arpad@pharm.unideb.hu (A. Tosaki).
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Speciﬁcations table
Subject area Chemistry, Biology
More speciﬁc subject area Organic chemistry, Pharmacology
Type of data 1H and 13C NMR spectra, HPLC-MS chromatograms, column tables
How data was acquired NMR Bruker DRX-400 spectrometer at 25 C, HPLC-MSLTQ XL linear ion trap mass
spectrometer coupled with Accela LC system (Thermo Fisher Scientiﬁc, Waltham, MA, USA).,
“Isolated working heart system”.
Data format Raw, ﬁltered and analyzed
Experimental factors Initial compounds were purchased, the intermediates and the end-product were synthesized as
described in the original paper.
Experimental features New compounds have been characterized by spectrometric methods and an ex vivo technique on
rat hearts
Data source location - Department of Pharmacology and Department of Bioanalytical Chemistry, Nagyerdei Krt
98, H-4032 Debrecen, Hungary
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Debrecen,
Egyetem ter 1, H-4032 Debrecen, Hungary
Data accessibility Data are provided with this article.
Related research article K. Szoke, A. Czompa, I. Lekli, P. Szabados-Furjesi, M. Herczeg, M. Csavas, A. Borbas, P.
Herczegh, A. Tosaki, A new, vasoactive hybrid aspirin containing nitrogen monoxide-
releasing molsidomine moiety, Eur. J. Pharm. Sci., 131, 2019, 159e166 [1].
Value of the data
 The NMR spectra can be used for structure elucidation of similar synthetic compounds.
 Dataset of stability tests could be used to pretest the degradation proﬁles of molecules planned to try in vivo
circumstances.
 The cardiac functions detailed here are important indicator related to the contractile activity of the myocardium (see
Fig. 2).
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Spectra from 1H and 13C NMRmeasurements are reported to prove the structure of the synthesized
compounds [1] (see Figs. 1e9). HPLC-MS measurements were used to study the oxidative stability of
the compound ERJ-500, representative total ion chromatogram of the oxidation by synthetic porphyrin
and the Chemical Fenton System can be seen (Figs. 10, 11). Cardiac parameters (aorta ﬂow, aortic
pressure, derivated aortic pressure, and cardiac output) were registered (Fig. 12) in “isolated working
hearts” treated with ERJ-500.
1.1. Characterization of new compounds
The 1H NMR (400 MHz) and 13C NMR (101 MHz) spectra were recorded with a Bruker DRX-400
spectrometer at 25 C. Chemical shifts are referenced to Me4Si (0.00 ppm for 1H) and to the residual
solvent signals (CDCl3: 77.1 for 13C).
1.2. Compound 5
1H NMR (400 MHz, CDCl3): d 8.03 (dd, J ¼ 7.8 Hz, J ¼ 1.8 Hz, 1H, arom), 7.53 (td, J ¼ 7.8 Hz, J ¼ 1.8 Hz,
1H, arom), 7.47e7.45 (m, 6H, arom), 7.30e7.19 (m, 10H, arom), 7.08 (dd, J ¼ 8.1 Hz, J ¼ 0.8 Hz, 1H),
4.41e4.39 (m, 2H, TEG-CH2), 3.78e3.76 (m, 2H, TEG-CH2), 3.70e3.65 (m, 10H, 5  TEG-CH2), 3.23 (t,
J ¼ 5.2 Hz, 2H, TEG-CH2), 2.34 (s, 3H, CH3 Ac); 13C NMR (101 MHz, CDCl3): d 169.9 (1C, Cq Ac), 164.5 (1C,
COO), 150.8 (1C, Cq arom), 144.2 (3C, Cq arom), 134.0, 132.0, 128.8, 127.9, 127.0, 126.1, 123.9 (19C, arom),
123.3 (1C, Cq arom), 86.6 (1C, Cq Tr), 70.9, 70.8, 70.7, 69.2, 64.4, 63.4 (8C, 8  TEG-CH2), 21.1 (1C, CH3 Ac).
1.3. Compound 6
1H NMR (400 MHz, CDCl3): d 8.05 (dd, J¼ 7.8 Hz, J¼ 1.6 Hz, 1H, arom), 7.56 (td, J¼ 7.9 Hz, J¼ 1.6 Hz,
1H, arom), 7.32 (td, J¼ 7.6 Hz, J ¼ 1.2 Hz, 1H, arom), 7.11 (dd, J¼ 8.1 Hz, J ¼ 1.2 Hz, 1H, arom), 4.45e4.43
Fig. 1. Structure of ERJ-500.
K. Sz}oke et al. / Data in brief 25 (2019) 104146 3(m, 2H, TEG-CH2), 3.81e3.78 (m, 2H, TEG-CH2), 3.74e3.65 (m, 10H, 5  TEG-CH2), 3.60e3.58 (m, 2H,
TEG-CH2), 2.62 (s, 1H, TEG-OH), 2.36 (s, 3H, CH3 Ac); 13C NMR (101 MHz, CDCl3): d 169.9 (1C, Cq COO),
164.5 (1C, Cq Ac),150.8 (1C, Cq arom),134.1,132.0,126.1,123.9 (4C, arom),123.2 (1C, Cq arom), 72.5, 70.8,
70.7, 70.6, 70.4, 69.2, 64.3, 61.8 (8C, 8  TEG-CH2), 21.1 (1C, CH3 Ac).
1.4. Compound 7
1H NMR (400 MHz, CDCl3): d 8.41 (s, 1H, CH sydnone), 8.27 (d, J ¼ 9.1 Hz, 2H, arom), 7.42 (d, J ¼ 9.1
Hz, 1H, arom), 3.87e3.85 (m, 2H, CH2 morpholine), 3.64e3.61 (m, 2H, CH2 morpholine); 13C NMR (101
MHz, CD3OD): d 183.5 (1C, Cq carbamate),167.0 (1C, Cq sydnone),134.5,132.1, (4C, arom),125.3 (1C, CH),
74.3, 62.9 (4C, 4  morfoline-CH2).
1.5. Compound ERJ-500
1H NMR (400 MHz, CDCl3): d 8.03 (dd, J¼ 7.9 Hz, J¼ 1.7 Hz, 1H, arom), 7.70 (s, 1H, CH sydnone), 7.56
(ddd, J¼ 8.1, 7.4,1.8 Hz,1H, arom), 7.31 (td, J¼ 7.7 Hz,1.1 Hz,1H, arom), 7.10 (dd, J¼ 8.1 Hz, J¼ 1.1 Hz,1H,Fig. 2. 1H NMR spectra of compound 5.
Fig. 3. 13C NMR spectra of compound 5.
Fig. 4. 1H NMR spectra of compound 6.
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Fig. 5. 13C NMR spectra of compound 6.
Fig. 6. 1H NMR spectra of compound 7.
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Fig. 7. 13C NMR spectra of compound 7.
Fig. 8. 1H NMR spectra of compound ERJ-500.
K. Sz}oke et al. / Data in brief 25 (2019) 1041466
Fig. 9. 13C NMR spectra of compound ERJ-500.
Fig. 10. Representative total ion chromatogram of the oxidation by synthetic porphyrin. On the control chromatogram (red) the peak
at 6.59 represents ERJ-500. After oxidation (green chromatogram) the peak of ERJ-500 at 6.58 remained unchanged.
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Fig. 11. Representative total ion chromatogram of the oxidation by the Chemical Fenton System. On the control chromatogram (red)
the peak at 6.54 represents ERJ-500. After oxidation (green chromatogram) the peak of ERJ-500 at 6.53 remained unchanged.
K. Sz}oke et al. / Data in brief 25 (2019) 1041468arom), 4.43e4.41 (m, 2H, CH2 morpholine), 4.26e4.24 (m, 2H, CH2 morpholine), 3.94e3.92 (m, 4H, 2
TEG-CH2), 3.80e3.78 (m, 2H, CH2 morpholine), 3.74e3.72 (m, 2H, CH2 morpholine), 3.68e3.63 (m, 8H,
4 TEG-CH2), 3.51e3.49 (m, 4H, 2 TEG-CH2), 2.35 (s, 3H, CH3 Ac); 13C NMR (101 MHz, CDCl3): d 174.2
(1C, Cq carbamate), 169.7 (1C, Cq COO), 164.4 (1C, Cq Ac), 161.2 (1C, Cq sydnone), 150.6 (1C, Cq arom),
133.8,131.8,125.9,123.7 (4C, arom),123.2 (1C, Cq arom), 70.6, 70.5, 69.3, 69.0, 65.4, 64.6, 64.3, 54.6 (13C,
1  sydnone-C, 4  morpholine-CH2, 8  TEG-CH2), 20.9 (1C, CH3 Ac).
1.6. Representative chromatograms of oxidative stability assays
Non-signiﬁcant myocardial parameters in working heart preparation.Aorta ﬂow Aortic pressure Derivated aortic
pressure
Cardiac output
Control ERJ-500 Control ERJ-500 Control ERJ-500 Control ERJ-500
22 46 87 100 740 1361 42 72
31 50 92,7 110 924 2159 51 73
25 32 110,9 104 1670 1666 39 58
48 38 99 106 1357 1938 69 57
42 42 102 102,6 1568 1783 62 66
34 42 105 109 1756 1786 54 66
40 106 1879 56
34 104 1873 52
46 99 1424 65
46 99 1558 65
46 113,5 1956 65
Fig. 12. Myocardial function. The results show aorta ﬂow, aortic pressure, derivated aortic pressure, and cardiac output in control
and ERJ-500 treated hearts.
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2.1. LC-MS measurements
The reaction mixture was analyzed with an LTQ-XL linear ion trap mass spectrometer coupled
with the Accela LC system (Thermo Fisher Scientiﬁc, Waltham, MA, USA). The HPLC separation
was performed using a Kinetex XB-C18 2.6 mm column, 0.1% formic acid in water, and ACN with
0.1% formic acid with gradient elution, and the ﬂow rate was set to 300 mL/min. The method
parameters for mass spectrometry were the followings: 35 a.u. sheath gas ﬂow rate, 5000 V
spray voltage, 275 C capillary temperature, 31 V capillary voltage, 150 V tube lens voltage, and
34 V skimmer voltage.2.2. Oxidation by synthetic porphyrin and the chemical Fenton system
Two reactions were carried out to test the stability of ERJ-500 molecule under oxidative conditions,
based on the method as reported by Csepanyi et al. [2] recently, with minor modiﬁcations as follows:
50 ml of ERJ-500 dissolved in acetonitrile was used for synthetic porphyrin oxidation in 10 mM con-
centration. 400 ml of ERJ-500 in 2.5 mM concentration for the Fenton reaction. Samples were drawn at
1 h in the Fenton reactions prior to injecting them instantly to the HPLC and further investigation.
Reaction mixtures for blank contained acetonitrile only without ERJ-500. The control mixtures con-
tained no peroxide.
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To measure cardiac function (Aortic ﬂow, Aortic pressure, Derivated aortic pressure, and Cardiac
output), isolated working heart preparations were carried out based on a previously described method
by Czompa et al. [3] on Sprague Dawley female rat hearts (n ¼ 11 in the control group, n ¼ 6 in the
treated group). After completing the isolated working heart preparation procedure followed by 10 min
washout period, and aorta ﬂow, aortic pressure, derivated aortic pressure, and cardiac output were
registered (Fig. 12). Cardiac output was calculated by the sum of aortic and coronary ﬂow represented
in the associated research article [1]. In the treated group, ERJ-500 was added to the KHB buffer by a
dilution of a previously prepared stock solution leading to a 100 mM concentration of ERJ-500 in the
inﬂow line. The molecule-containing KHB buffer was presented after the washout and baseline
registration period for 5 min, followed by a 30 min ischemia and 90 min of reperfusion.
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